THC

THC

USD

Tenet Healthcare Corporation Common Stock

$148.030+2.530 (1.739%)

Real-time Price

Healthcare
Medical Care Facilities
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$145.500

High

$149.570

Low

$145.270

Volume

0.21M

Company Fundamentals

Market Cap

13.7B

Industry

Medical Care Facilities

Country

United States

Trading Stats

Avg Volume

1.75M

Exchange

NYQ

Currency

USD

52-Week Range

Low $109.82Current $148.030High $171.2

AI Analysis Report

Last updated: May 2, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

THC: Tenet Healthcare Corporation Common Stock - What's Driving the Recent Action and What Might Be Next?

Stock Symbol: THC Generate Date: 2025-05-02 23:25:34

Alright, let's break down what's been going on with Tenet Healthcare stock lately. We've got some fresh news, a look at how the price has moved, and even a peek at what an AI model thinks is coming.

Recent News Buzz: Mostly Good Vibes

The news flow around THC has been pretty upbeat in the last few days of April. The biggest splash came from the company itself, reporting some seriously strong numbers for the first quarter of 2025. We're talking net income hitting $406 million, which translates to $4.27 per share. Even better, their adjusted earnings per share jumped a solid 35.4% compared to the same time last year. That's a clear sign the business is performing well right now.

Following those good earnings, a few big investment banks chimed in. Barclays, RBC Capital, and UBS all kept their positive ratings on the stock ("Overweight," "Outperform," and "Buy," respectively). Not only that, but they also raised their price targets. UBS is the most bullish, bumping their target all the way up to $230. RBC went to $189, and Barclays to $171. This tells us that analysts who follow the company closely are feeling more confident about its future value after seeing the latest results.

Now, it wasn't all sunshine. A couple of weeks earlier, back in mid-April, Baird actually downgraded the stock and lowered their price target. But looking at the more recent news, especially the earnings report and the subsequent analyst upgrades, the overall sentiment has definitely swung positive.

Price Check: A Big Jump Lately

Looking at the stock's journey over the last month or so, it's been a bit of a rollercoaster. The price dipped quite a bit through March and into early April, hitting a low around $109.82 on April 21st. Ouch.

But then, something shifted. Right around the time of that strong earnings report (April 29th), the stock saw a significant pop. It jumped from around $128 to over $138 in one day, and it's kept climbing since. The last price we have data for is $148.03 on May 2nd. So, after a rough patch, the stock has seen a sharp move upwards, likely fueled by that positive news.

What about the immediate future? An AI prediction model is forecasting continued upward movement, suggesting a gain of 0.74% today, 2.57% tomorrow, and 4.09% the day after. That aligns with the recent positive momentum.

Putting It Together: Outlook & Ideas

Based on the combination of strong earnings, multiple analysts raising their price targets, the stock's recent upward surge, and the AI's positive short-term forecast, the near-term picture for THC looks quite favorable. It seems the market is reacting positively to the company's performance and the increased confidence from analysts.

What might this suggest? The current situation seems to lean towards favoring potential buyers or those looking to add to their position. The momentum is clearly positive right now.

Potential Entry Consideration: The stock has already made a big move. The AI model suggested potential entry points slightly below the current price, around $146.61 or $147.57. While the price is just above that now, if you're considering getting in, you might look at the current level or perhaps wait for any minor dip back towards that $147-$148 area. The recent price action shows strong buying interest around these levels following the earnings news.

Potential Exit/Stop-Loss Consideration: Managing risk is always key. The AI model gave a very short-term take profit idea at $148.19, which is basically right where the stock is now – maybe useful for super quick trades, but the analyst targets are much higher. Those higher targets ($171, $189, $230) could be seen as potential upside goals over a longer timeframe if the positive trend continues. For a stop-loss, the AI suggested $130.75. This level is well below the recent jump and could serve as a point to reconsider if the positive momentum completely reverses. Setting a stop-loss below the low of the big jump day (around $126.75 on April 29th) could also be a strategy to protect against a breakdown of the recent rally.

Company Context

Just a quick reminder about Tenet Healthcare: they're a big player in the healthcare services world, running hospitals and outpatient centers. So, when they report strong earnings like they just did, it tells us their core business of providing medical care is doing well. While they do carry a good amount of debt (something to be aware of), their recent profitability and return on equity look solid. The positive news and analyst views are directly tied to how well they're executing in their industry.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Related News

Analyst Upgrades

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $171

Barclays analyst Andrew Mok maintains Tenet Healthcare with a Overweight and raises the price target from $161 to $171.

View more
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $171
Analyst Upgrades

RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $189

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare with a Outperform and raises the price target from $183 to $189.

View more
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $189
Analyst Upgrades

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $230

UBS analyst A.J. Rice maintains Tenet Healthcare with a Buy and raises the price target from $217 to $230.

View more
UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $230
BusinessWire

Tenet Reports Strong First Quarter 2025 Results

Net income available to common shareholders in first quarter 2025 was $406 million, or $4.27 per diluted share Adjusted diluted earnings per share1 increased 35.4% to $4.36 in first quarter 2025 compared to $3.22 in

View more
Tenet Reports Strong First Quarter 2025 Results
Analyst Upgrades

Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

Baird analyst Michael Ha downgrades Tenet Healthcare from Outperform to Neutral and lowers the price target from $153 to $137.

View more
Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

AI PredictionBeta

AI Recommendation

Bullish

Updated at: May 4, 2025, 01:55 AM

BearishNeutralBullish

72.2% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
ValueConservativeAggressive
Trading Guide

Entry Point

$148.45

Take Profit

$158.46

Stop Loss

$133.24

Key Factors

DMI shows bearish trend (ADX:20.5, +DI:5.5, -DI:6.1), suggesting caution
Current Price is extremely close to support level ($148.03), suggesting strong buying opportunity
Trading volume is 7.1x average (17,556), indicating extremely strong buying pressure
MACD -0.1608 is above signal line -0.2017, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.